Stay updated on Durvalumab in Resectable Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.

Latest updates to the Durvalumab in Resectable Lung Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. The funding lapse notice and the previous Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide funding status notice was added and the record history now shows revision v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check28 days agoChange DetectedShow glossary option added and color-coded diffs (green for additions, red for deletions) on the history page. Revision note updated to v3.4.0 and older revision text removed along with the No FEAR Act data reference.SummaryDifference0.5%

- Check35 days agoChange DetectedA minor metadata update to the revision tracking shows v3.3.4 added and v3.3.3 removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check64 days agoChange DetectedRevision: v3.3.3 was added to the page history, and the HHS Vulnerability Disclosure entry and Revision: v3.3.2 were removed from the footer. These changes modify only page metadata and navigation aids, not the study information or primary functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check85 days agoChange DetectedThe page footer now displays Revision: v3.3.2, replacing the previous v3.3.1.SummaryDifference0.1%

Stay in the know with updates to Durvalumab in Resectable Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab in Resectable Lung Cancer Clinical Trial page.